Strikingly, high Glut5 expression was found in glioma cells, acute myeloid diseases and breast cancer cells, and aberrant Glut5 expression was associated with malignant progression and poor patient survival, revealing the potential involvement of Glut5 in tumorigenesis 19-21. This evidence concerns the gene SLC2A5 and central nervous system cancer.